Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene

被引:76
作者
Holzapfel, HP
Wonerow, P
vonPetrykowski, W
Henschen, M
Scherbaum, WA
Paschke, R
机构
[1] UNIV LEIPZIG, ZENTRUM INNERE MED, MED KLIN & POLIKLIN 3, DEPT INTERNAL MED 3, D-04103 LEIPZIG, GERMANY
[2] UNIV FREIBURG, CHILDRENS HOSP, FREIBURG, GERMANY
关键词
D O I
10.1210/jc.82.11.3879
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neonatal hyperthyroidism in the absence of maternal autoimmune thyroid disease and without thyroid-stimulating antibodies in the child is rare. We here describe a boy with severe intrauterine hyperthyroidism and advanced bone age in the absence of thyroid-stimulating autoantibodies. After long term antithyroid treatment and relapse of hyperthyroidism, a near-total thyroid resection was performed. The necessity to progressively decrease postoperative thyroid hormone replacement indicates thyroid tissue regrowth in the small thyroid remnant. Analysis of the genomic DNA of the child's peripheral leukocytes showed a G to A base exchange that led to a heterozygous Ser to Asn conversion at position 505 in the third trans-membrane region of the TSH receptor (TSHR). The absence of the Ser(505)Asn mutation in all other family members identifies the child's TSHR mutation as a sporadic germline mutation. Transient expression of the mutated TSH receptor in COS-7 cells showed a constitutively activated cAMP cascade. We thus identified a new constitutively activating germline mutation. Neonates with persistent nonautoimmune hyperthyroidism should be investigated for TSHR germline mutations. Because of frequent relapses, patients with sporadic congenital nonautoimmune hyperthyroidism should be treated with early subtotal to near-total thyroid resection. Moreover, post operative radioiodine treatment should be considered.
引用
收藏
页码:3879 / 3884
页数:6
相关论文
共 25 条
[1]  
Ausubel FA, 1995, CURRENT PROTOCOLS MO
[2]   A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism [J].
DeRoux, N ;
Polak, M ;
Couet, J ;
Leger, J ;
Czernichow, P ;
Milgrom, E ;
Misrahi, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2023-2026
[3]   GERMLINE MUTATIONS IN THE THYROTROPIN RECEPTOR GENE CAUSE NON-AUTOIMMUNE AUTOSOMAL-DOMINANT HYPERTHYROIDISM [J].
DUPREZ, L ;
PARMA, J ;
VANSANDE, J ;
ALLGEIER, A ;
LECLERE, J ;
SCHVARTZ, C ;
DELISLE, MJ ;
DECOULX, M ;
ORGIAZZI, J ;
DUMONT, J ;
VASSART, G .
NATURE GENETICS, 1994, 7 (03) :396-401
[4]  
FUHRER D, 1996, THYROID S1, V6
[5]  
HORTON GL, 1985, ANN ENDOCRINOL-PARIS, V48, P92
[6]   MAPPING THE BINDING-SITE CREVICE OF THE DOPAMINE D2 RECEPTOR BY THE SUBSTITUTED-CYSTEINE ACCESSIBILITY METHOD [J].
JAVITCH, JA ;
FU, DY ;
CHEN, JY ;
KARLIN, A .
NEURON, 1995, 14 (04) :825-831
[7]  
JIANG Q, 1996, HYDROPHILIC SIDE SHA
[8]  
KOHLER B, 1996, P INT C END, P641
[9]   BRIEF REPORT - CONGENITAL HYPERTHYROIDISM CAUSED BY A MUTATION IN THE THYROTROPIN-RECEPTOR GENE [J].
KOPP, P ;
VANSANDE, J ;
PARMA, J ;
DUPREZ, L ;
GERBER, H ;
JOSS, E ;
JAMESON, JL ;
DUMONT, JE ;
VASSART, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (03) :150-154
[10]   INCIDENCE OF JUVENILE THYROTOXICOSIS IN DENMARK, 1982-1988 - A NATIONWIDE STUDY [J].
LAVARD, L ;
RANLOV, I ;
PERRILD, H ;
ANDERSEN, O ;
JACOBSEN, BB .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (06) :565-568